Showing results (421-430 of 580) with videos related to
Sort By:
Pageof 58
Clinical Journal of the American Society of Nephrology : CJASN|October 8, 2011
Serum erythropoietin level and mortality in kidney transplant recipientsMiklos Z Molnar, Adam G Tabak, Ahsan Alam, et al.Journal of Managed Care & Specialty Pharmacy|October 1, 2021
Association of dyskalemias with short-term health care utilization in patients with advanced CKDAnkur A Dashputre, Justin Gatwood, Keiichi Sumida, et al.Journal of Clinical Lipidology|February 20, 2018
Increments in serum high-density lipoprotein cholesterol over time are not associated with improved outcomes in incident hemodialysis patientsTae Ik Chang, Elani Streja, Melissa Soohoo, et al.Sleep Medicine|February 5, 2011
High risk of obstructive sleep apnea is a risk factor of death censored graft loss in kidney transplant recipients: an observational cohort studyAndras Szentkiralyi, Maria E Czira, Miklos Z Molnar, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 27, 2017
Intradialytic hypotension, blood pressure changes and mortality risk in incident hemodialysis patientsJason A Chou, Elani Streja, Danh V Nguyen, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 13, 2020
Eosinophil count and mortality risk in incident hemodialysis patientsDuk-Hee Kang, Yuji Lee, Carola Ellen Kleine, et al.American Journal of Nephrology|July 21, 2021
Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to DialysisAnkur A Dashputre, Keiichi Sumida, Fridtjof Thomas, et al.Journal of Cachexia, Sarcopenia and Muscle|July 11, 2012
Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literatureSapna S Patel, Miklos Z Molnar, John A Tayek, et al.Lancet Regional Health. Americas|July 12, 2024
Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based studyYoko Narasaki, Csaba P Kovesdy, Amy S You, et al.Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2010
Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney diseaseKamyar Kalantar-Zadeh, Lisa Gutekunst, Rajnish Mehrotra, et al.Pageof 58